InvestorsHub Logo
Followers 3420
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: Investor100 post# 13255

Monday, 06/01/2009 12:33:40 AM

Monday, June 01, 2009 12:33:40 AM

Post# of 97239
Investor100...w/TELK that is some pretty good data. The trend was toward survival in the treatment arm with the TELIK drug even though the study was not statistically powered for overall survival. Safety data was good as well. The PFS was almost 2 months greater in the treatment arm vs control arm. Not sure it will cause the stock to set fire but it allows the study to move into a potential pivotal Phase III trial.

Best, Sheff

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.